Hepatitis as a World Health Problem

Abstract

Viral hepatitis is a health problem affecting hundreds of millions of people worldwide. The morbidity and mortality from viral hepatitis is enormous and affects all age groups. Hepatitis A and E are enterically transmitted viruses, which are spontaneously cleared by the host and do not lead to chronic infection. Hepatitis B may be spread vertically, sexually or parenterally whereas hepatitis C is most often acquired parenterally from contaminated blood products (historically) or via the use of intravenous drugs. Both of these infections may lead to chronic hepatitis and cirrhosis with its attendant complications including portal hypertension, liver failure and hepatocellular carcinoma. Hepatitis D can only cause infection together with hepatitis B. It may lead to an aggressive hepatitis as well as chronicity. Although our knowledge of viral genetics, epidemiology and treatment options is increasing, prevention remains the most cost effective method of controlling viral hepatitis.

Keywords: hepatitis; world; prevention; immunization; treatment

Figure 1.

Typical clinical and serological features of hepatitis A infection. HAV, Hepatitis A virus; Ig immunoglobulin.

Figure 2.

Clinical and serological profile of acute hepatitis B with resolution. DNA, deoxyribonucleic acid; HBcAb, hepatitis B core antibody; HBeAg/Ab, hepatitis B e antigen/antibody; HBsAg/Ab, hepatitis B surface antigen/antibody; HBV, Hepatitis B virus.

Figure 3.

Clinical and serological profile of chronic hepatitis B (adult acquisition). DNA, deoxyribonucleic acid; HBcAg/Ab, hepatitis B core antigen/antibody; HBeAg/Ab, hepatitis B e antigen/antibody; HBsAg, hepatitis B surface antigen; HBV, Hepatitis B virus.

close

References

Alter MJ (1991) Epidemiology of community‐acquired hepatitis C. In: Hollinger FB, Lemon SM and Margolis HS (eds) Viral Hepatitis and Liver Disease, pp. 410–413. Baltimore, MD: Williams & Wilkins.

Farci P, Mandas A, Coiana A et al. (1994) Treatment of chronic hepatitis D with interferon alpha‐2a. New England Journal of Medicine 330(2): 88–94.

Jonas MM (2000) Viral hepatitis from prevention to antivirals. Clinics in Liver Disease 4(4): 849–877.

Kenny‐Walsh E (1999) Clinical outcomes after hepatitis C infection from contaminated anti‐D immune globulin. Irish Hepatology Research Group. New England Journal of Medicine 340(16): 1228–1233.

Merican I, Guan R, Amarapuka D et al. (2000) Chronic hepatitis B virus infection in Asian countries. Journal of Gastroenterology and Hepatology 15(12): 1356–1361.

Moreno‐Otero R (2005) Therapeutic modalities in hepatitis C: challenges and development. Journal of Viral Hepatitis 12(1): 10–19.

Visvanathan K and Lewin SR (2006) Immunopathogenesis: role of innate and adaptive immune responses. Seminars in Liver Disease 26(2): 104–115.

Willner IR, Uhl MD, Howard SC et al. (1998) Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Annals of Internal Medicine 128(2): 111–1114.

Yuen MF, Wong DK, Sum SS et al. (2005) Effect of lamivudine therapy on the serum covalently closed‐circular (ccc) DNA of chronic hepatitis B infection. American Journal of Gastroenterology 100(5): 1099–1103.

Further Reading

Arguedas MR and Fallon MB (2001) Prevention in liver disease. American Journal of Medical Science 321(2): 145–151.

Bonanni P and Bonaccorsi G (2001) Vaccination against hepatitis B in health care workers. Vaccine 19(17–19):2389–2394.

Chu CM and Liaw YF (2006) Hepatitis B virus‐related cirrhosis: natural history and treatment. Seminars in Liver Disease 26(2): 142–152.

Medley GF, Lindop NA, Edmunds WJ and Nokes DJ (2001) Hepatitis B virus endemicity: heterogeneity, catastrophic dynamics and control. Nature Medicine 7(5): 619–624.

Terrault NA and Wright TL (1998) Viral hepatitis A through G. In: Feldman M, Scharschmidt BF and Sleisenger MH (eds) Sleisenger and Fordtran's Gastrointestinal and Liver Disease, pp. 1123–1170. Philadelphia: Saunders.

Keeffe EB (2005). Hepatitis C virus. Clinics in Liver Disease 9(3). Philadelphia, PA: Saunders.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Bain, Vincent G, and Tandon, Puneeta(Jul 2007) Hepatitis as a World Health Problem. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0002236.pub2]